Hadassah Cardiologists Find That Vitamin D Supplementation Increases Survival for Heart Failure Patients
Noting that Vitamin D deficiency is "highly prevalent" in patients with heart failure (HF) and "a significant predictor of reduced survival," Hadassah Medical Center physicians determined that Vitamin D supplementation was associated with improved outcome.
The researchers reported their findings in the April 2012 issue of The European Journal of Heart Failure, the international journal of the European Society of Cardiology, dedicated to the advancement of knowledge in the field of heart failure.
Vitamin D deficiency was found in 28 percent of the HF patients, as compared to 22 percent in the control group. Only 8.8% of the HF patients, they found, had optimal levels of Vitamin D. Those HF patients who received Vitamin D supplementation, however, were 32 percent less likely to die from the disease.
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>